PHL delivers strong FY26 result and sets dividend policy

Full Year Results to March 2026
28 May 2026
FULL YEAR RESULTS TO MARCH 2026
Promisia delivers strong FY26 result and introduces dividend policy
Promisia Healthcare Limited (NZX: PHL) has released its unaudited preliminary results for the year
ended 31 March 2026, reporting strong performance across its key financial and operational
measures.
FY26 Results Summary:
• Operating revenue increased 29% to $40.1 million
• Underlying EBITDAF
1
increased 58% to $6.6 million
• Net profit after tax increased 89% to $12.9 million
• Net operating cash flows increased 87% to $6.4 million
• Aggregate market valuation increased 17.1% to $107.2 million
• Net tangible assets (NTA) per share increased 38% to $1.09
• Loan-to-value ratio reduced to 31.8% from 42.9%
• Group care occupancy increased from 87% to 94%

Promisia Chair Rhonda Sherriff said: “FY26 has been a strong year for Promisia. Occupancy, earnings,
cash flow, balance sheet strength and care quality have all materially improved over the year.
“That was not driven by one facility or one initiative. The improvement reflects the delivery of the
plan we set at the start of the year: focus on residents and care quality, lift occupancy, strengthen
the systems and processes across our facilities, and build the platform for growth.
“The result gives the Board confidence that Promisia is entering FY27 with momentum, further
earnings growth ahead and, for the first time, a dividend policy linked to Operating Free Cash Flow
2
.”
Financial Highlights:
FY26 delivered a clear step change in financial performance.
Operating revenue increased 29% to $40.1 million, supported by higher occupancy, the first full-year
contribution from the Cromwell operations, and growth in deferred management fees. Underlying
EBITDAF increased 58% to $6.6 million, up from $4.2 million in FY25.
Net profit after tax increased 89% to $12.9 million, supported by the stronger operating result and
fair value gains from the revaluation of Promisia’s care facilities and retirement villages. The
aggregate market valuation increased by $15.7 million to $107.2 million at 31 March 2026, with each
site increasing in value by at least 10%. This reflects broad-based improvement across the portfolio,
rather than a single asset or one-off valuation movement.
NTA per share increased from $0.79 to $1.09, an increase of 38%. This continues the value-creation
trend over recent years, with NTA per share more than doubling from $0.46 at March 2023.

1
EBITDAF is operating earnings before interest, tax, depreciation, amortisation and fair value adjustments and is a non-GAAP number.
Underlying EBITDAF excludes transactions considered to be non-trading in nature or size. Excluding these transactions from normalised
earnings can assist users in forming a view of the underlying performance of the Group.

2
Operating Free Cash Flow is calculated from Underlying EBITDAF, less cash interest, required debt repayments, cash tax payable for the
year and maintenance capital expenditure. Operating Free Cash Flow is a non-GAAP cash measure.

During the year, Promisia completed a comprehensive debt restructure, consolidating its BNZ
lending into a single Group-level facility. The restructure created a simpler and more scalable debt
structure, improved visibility over future interest costs and strengthened the Group’s funding
platform.
Borrowing costs reduced to $2.31 million from $2.45 million. The weighted average interest rate
reduced to 5.7% from 7.1%, with interest rate swaps now providing greater cash flow certainty over
the next two to four years. As the debt restructure was completed in December 2025, the full-year
benefit of lower interest costs will flow through in FY27.
Loan-to-value ratio reduced to 31.8% at year end, with more than $3.0 million of cash and undrawn
facilities available.
Operational highlights
A key driver of the FY26 result has been the strengthening of Promisia’s leadership team. Graeme
Dodd joined as Chief Operating Officer in May 2025 and has worked closely with Chief Financial
Officer Francisco Rodriguez Ferrere to lift performance across all areas of the business. This has
meant clearer accountability, more structured support for facility managers, better reporting and a
more disciplined focus on occupancy, care quality and financial performance.
Occupancy was a major driver of the year’s result, increasing from 87% at March 2025 to 94% at
year end.
Nelson Street’s conversion of rest home beds to dementia care was completed during the year,
alongside the addition of hospital-level care, and the facility is now effectively full. Ranfurly Manor’s
care suite sell-down is complete, supporting deferred management fee growth and increased cash
flow from Occupation Right Agreement (ORA) resales. Aldwins House reached its highest-ever
occupancy during the year, with improved culture, reputation and care quality under stronger local
leadership. Golden View and Ripponburn are now fully integrated into Promisia, with sustained
regional demand and the benefits of scale and operational alignment now embedded.
Promisia also strengthened its operating model during the year through supplier consolidation,
standardised systems, roster reviews and consistent processes across the portfolio.
Care quality also progressed during the year, with key clinical and quality indicators improving across
the Group. This reflects enhanced clinical oversight, better use of data and benchmarking, and the
standardisation of our resident management system across all sites.
Dividend policy
The Board has introduced a formal dividend policy for FY27.
The policy is based on Operating Free Cash Flow rather than accounting profit. This means dividends
will be assessed from cash generated by the business after allowing for cash interest, required debt
repayments, cash tax payable and maintenance capital expenditure.
Operating Free Cash Flow will become a key measure for the Group going forward, and Promisia
expects to report against it as part of its regular financial updates. This will give shareholders a
clearer view of the cash available to support dividends, reinvestment and future growth.

Dividends will be assessed at 20% to 40% of Operating Free Cash Flow and are intended to be fully
imputed. Any dividend will remain at the Board’s discretion, taking into account the Group’s
financial performance, financial position, funding requirements and growth opportunities at the
time.
The policy reflects the stronger earnings base and improved cash generation achieved during FY26,
while maintaining balance sheet discipline and capacity to reinvest in the business.
Outlook
Promisia enters FY27 with stronger earnings, improved cash flow and a financial platform that
supports growth.
For FY27, Promisia expects underlying EBITDAF to increase to at least $8.0 million, representing
more than 20% year-on-year growth. This guidance is based on the existing portfolio, with Group
care occupancy expected to lift to at least 95%.
Operating Free Cash Flow is also expected to materially improve from FY26, supporting the ability to
pay a dividend under the new policy while continuing to reinvest in the business.
Promisia is actively working towards an earnings-accretive acquisition in FY27. This is consistent with
the company’s strategy of growing through large-scale integrated care and village facilities that align
with its operating model.
The FY26 result has created a clear platform for FY27: higher occupancy, improving cash flow,
dividend capacity and disciplined growth.
ENDS
Approved for release by Promisia Chair, Rhonda Sherriff
For media or investor assistance, please contact:
Francisco Rodriguez Ferrere, Chief Financial Officer, Promisia Healthcare Limited
Phone: +64 21 245 1801 or email: Francisco.rf@promisia.co.nz

About Promisia Healthcare
Promisia is a New Zealand aged care and retirement living provider, creating places where people
feel safe, known and truly at home. We are large enough to invest, improve and deliver reliably—yet
small enough to stay personal, local and deeply connected to the communities we serve. Our
purpose is simple: to build connected communities where people feel cared for, included and
valued. We aim to be the provider of choice in each community we operate in, with care facilities
and retirement villages in well-established, well-serviced towns and metropolitan areas. We are
committed to growing sustainably and profitably by doing the basics exceptionally well: delivering
quality care to residents, peace of mind to families and whānau, and long-term value for our care
homes, villages, communities and shareholders. Promisia is listed on the NZX (NZX: PHL).
http://www.promisia.co.nz.

---

1
FY26 Full Year Results
For the year ended 31 March 2026
Investor Presentation

2
Material improvement across all key financial and operational metrics, a result of
progressing our clear strategic priorities.
FY26: focused execution, delivering outperformance
$40.1m
Operating revenue
+29% vs FY25
$6.6m
Underlying EBITDAF
+58% vs FY25
94%
Group care occupancy
87% (Mar 25)
$6.4m
Net operating cash flows
+87% vs FY25
$1.09
NTA per share
+38% vs FY25
31.8%
Loan to Value ratio
42.9% (Mar 25)

3
Key operational highlights
Nelson Street repositioned to meet demand
The dementia conversion was completed in June 2025
and the facility is now effectively full, reflecting the
success of repositioning the site toward hospital and
dementia care.
Ranfurly care suite programme completed
The care suite sell-down strengthened steadily through
FY26 and is now complete, driving DMF growth, cash
flow and a material lift in site performance.
We set clear operational priorities at the start of the year and delivered against them, lifting performance
across the portfolio through stronger execution, clinical standards and operational discipline.
Cromwell embedded into the Group
Golden View and Ripponburn are now fully integrated
into Promisia, with strong regional demand and the
benefits of scale and operational alignment coming
through.
Aldwins operational reset
Occupancy, culture, reputation and care quality
improved under stronger local leadership, with the site
reaching its highest-ever occupancy during the year.
Operating model strengthened across the Group
Targeted operating improvements, including supplier consolidation, systems, roster reviews and standardised
processes, strengthened execution across the portfolio and built a more scalable operating platform.

4
Revenue and cost control delivering earnings growth
▲Operating revenue increased 29% to $40.1m
Driven by higher occupancy, a full year of Cromwell trading,
and growth in deferred management fees.
▲Operating expenses managed effectively
Operating expenses were $30.2m, up 22%, reflecting a full year
of Cromwell operating costs, while remaining below revenue
growth through efficient rostering and group-wide
procurement initiatives.
▲Administration costs remained tightly controlled
Administration expenses were $3.5m, up 2% despite the larger
Group, reflecting continued support office cost discipline.
▲Underlying EBITDAF
1
increased to $6.61m
Up from $4.19m in FY25 and $3.76m in FY24, representing 58%
year-on-year growth and 76% growth over two years.
1 EBITDAF is operating earnings before interest, tax, depreciation, amortisation and fair value adjustments and is a non-GAAP number. Underlying EBITDAF excludes transactions considered
to be non-trading in nature or size. Excluding these transactions from normalised earnings can assist users in forming a view of the underlying performance of the Group
$3.76m
$4.19m
$6.61m
Mar 24Mar 25Mar 26
Underlying EBITDAF
1
+76% over 2 years

5
$0.46
$0.63
$0.79
$1.09
Mar 23Mar 24Mar 25Mar 26
NTA per share
Building a track record of value creation
▲NTA per share increased 38% to $1.09
Up from $0.79 at March 2025, and more than double the $0.46
recorded at March 2023.
▲Portfolio valuation increased 17.1% to $107.2m
The aggregate market valuation increased by $15.7m, from
$91.5m to $107.2m at 31 March 2026.
▲Uplift achieved across all five sites
Each site increased in value by at least 10%, reflecting broad-
based improvement rather than a single asset or one-off
valuation movement.
▲Cash flow growth is driving value
The valuation increases are underpinned by stronger cash
flows, driven by higher occupancy, improved site performance
and targeted operating initiatives.
+137% over 3 years
A stronger operating platform and asset base now provide a clear foundation for continued growth.

6
Simplified debt profile
Bank debt
•Single bank lender (BNZ) with one consolidated facility, cross-
securitised across the group
•$31.1m total facility, with $3.3m undrawn for operating liquidity
•Weighted average interest rate on drawn debt c.5.7%, down
significantly from 7.1% at March 2025
•Interest rate swaps cover $22.0m of the $31.1m BNZ facility on a
staggered 2–4 year profile, supporting cash flow certainty
•LVR of 31.8%, continuing the reduction from 42.9% at March 2025
Vendor financing and convertible notes
•Vendor loans and convertible notes relate to the staged acquisition
of Golden View Village, with nominal amounts outstanding of
$12.25m and $3.5m.
•Both are non-interest bearing and effectively represent deferred
purchase price for full ownership of Golden View Village in 2028
59.1%
48.8%
42.9%
31.8%
Mar 23Mar 24Mar 25Mar 26
Group LVR on secured bank debt

7
Allocating capital to grow long-term shareholder value
Advancing ownership of Golden View Village
$2.16m p.a. of interest-free loan repayments directed
towards full ownership of Golden View Village. This is an
investment into a value-accretive asset, supporting
future NTA and cash flow uplift.
Targeted value-add capex
Selective capex focused on strong returns, protecting
facility quality and maintaining long-term asset values.
E.g. solar panel rollouts at Ranfurly Manor and Nelson
Street.
Maintaining a strong, flexible balance sheet
Continued focus on healthy liquidity and leverage
discipline, with LVR at 31.8% and over $3m of undrawn
facilities supporting working capital and future capital
flexibility.
Pursuing earnings-accretive acquisitions
Targeting large-scale integrated care and village assets
aligned with our operating model and strategic vision.
Our capital management framework prioritises four core areas, with shareholder returns now supported
through the new dividend policy.
Dividend policy now implemented
Providing a cash return to shareholders linked to operating free cash flow, whilst maintaining disciplined
reinvestment, growth and long-term shareholder value.

8
A disciplined, cash-based
dividend policy
Promisia has adopted a cash-based dividend policy from
FY27.
The policy is designed to return a portion of operating free
cash flow to shareholders over time, while maintaining
balance sheet strength and supporting reinvestment for
future growth.
Dividends will be assessed as 20–40% of Operating Free
Cash Flow (OFCF) and are intended to be fully imputed.
This remains consistent with Promisia’s capital allocation
framework of creating long-term shareholder value through
disciplined reinvestment, balance sheet strength and
earnings-accretive growth.
Any dividend will remain at the Board’s discretion, taking
account of the Group’s financial performance, financial
position and funding requirements at the time.
Underlying EBITDAF
1
Cash interest &
required debt repayments
Cash tax
Maintenance capex
Operating Free Cash Flow (OFCF)
Less:
Ordinary Dividend:
20% – 40% of OFCF
Cash interest &
required debt repayments
2
Cash tax
Maintenance capex
3
1 Underlying EBITDAF is a non-GAAP financial measure and represents earnings before interest, tax,
depreciation, amortisation and fair value movements, adjusted for non-recurring items.
2 Required debt repayments means scheduled principal repayments and other committed debt
amortisation under financing arrangements, including vendor loan repayments.
3 Maintenance capex represents expenditure required to maintain the existing asset base;
depreciation is currently used as a practical proxy.

9
FY27 Outlook
Continued earnings and cash flow growth
•Underlying EBITDAF expected to increase to at
least $8.0m (+20% YoY growth)
•Group care occupancy expected to lift to at least 95%
•Operating free cash flow expected to materially
improve from FY26, supporting the ability to pay a
dividend under the new policy
•Separately, Promisia is actively working towards an
earnings-accretive acquisition in FY27
•Earnings guidance is based on the existing portfolio
and excludes any future acquisitions or other material
capital activity
Golden View Village, Cromwell

10
Appendix: Promisia at a glance
Feilding
Ranfurly Manor
Nelson Street
Christchurch
Aldwins House
Cromwell
Golden View
Ripponburn
FacilityCare beds
Care suites /
Apartments
Villas
Ranfurly Manor1045738
Nelson Street47--
Aldwins House144--
Golden View 6019102
Ripponburn46-16
Total40176156
Five
Communities
450+
Incredible staff
650+
Residents
Promisia Healthcare is a New Zealand-based provider of residential
aged care and retirement village living, dedicated to delivering
high-quality care and support

11
Appendix: Our strategic vision for a stronger Promisia
Connected communities
where people feel cared for, included and valued
Delivery
An integrated network
meeting the
expectations of
residents and their
families with safe,
personalised and
individualised care
Growth
Focus on acquiring,
developing and
integrating medium-
large sized care
facilities in areas
offering value-
enhancement
opportunities
Diversification
Develop new revenue
streams from
independent living
options, extending the
range of services and
investing in additional
higher care beds
Our
Aspiration
Drivers
Enablers
Occupancy
Provider of choice
delivering a minimum
95% occupancy rate
across all facilities
Employment
brand of choice
A trusted and sustainable provider of quality people-care in the communities we serve
Vision
People
Expert governance;
accessible leadership;
skilled, experienced,
and engaged team
members
Efficiently run a
profitable business
operation
Disciplined use of
shareholder funds
Active reputation
and brand
management
Employment brand
of choice
Disciplined use of
shareholder funds
Active reputation
and brand
management

12
Appendix: Underlying EBITDAF and OFCF Calculation
Year ended 31 March ($000)20262025
Profit before income tax13,9406,681
Plus: Depreciation expense519409
Plus: Impairment losses37491
Plus: Finance costs3,5652,904
Plus: EBITDA from discontinued operations -927
EBITDA18,06111,412
Less: Fair value movement in property(11,651)(173)
Less: Bargain purchase on business acquisitions-(6,609)
EBITDAF6,4104,630
Less: Debt reduction income-(799)
Plus: Discretionary Executive Director payment155244
Plus: Non-recurring management share incentives48117
Underlying EBITDAF6,6134,192
Less: Net borrowing costs (2,313)(2,448)
Less: Committed debt amortisation (2,577)(2,230)
Less: Income tax paid/payable(1,373)(381)
Less: Maintenance capital expenditure (519)(409)
Operating Free Cash Flow (OFCF)(169)(1,276)

13
Disclaimer
This presentation has been prepared by Promisia Healthcare Limited (“PHL”). The information in this presentation is of a general nature only.
It is not a complete description of PHL.
This presentation is not a recommendation or offer of financial products for subscription, purchase or sale, or an invitation or solicitation for
such offers.
This presentation is not intended as investment, financial or other advice and must not be relied on by any prospective investor. It does not
take into account any particular prospective investor’s objectives, financial situation, circumstances or needs, and does not purport to
contain all the information that a prospective investor may require. Any person who is considering an investment in PHL securities should
obtain independent professional advice prior to making an investment decision, and should make any investment decision having regard to
that person’s own objectives, financial situation, circumstances and needs.
Past performance information contained in this presentation should not be relied upon (and is not) an indication of future performance.
This presentation may also contain forward looking statements with respect to the financial condition, results of operations and business,
and business strategy of PHL. Information about the future, by its nature, involves inherent risks and uncertainties. Accordingly, nothing in
this presentation is a promise or representation as to the future or a promise or representation that a transaction or outcome referred to in
this presentation will proceed or occur on the basis described in this presentation. Statements or assumptions in this presentation as to
future matters may prove to be incorrect.
A number of financial measures are used in this presentation and should not be considered in isolation from, or as a substitute for, the
information provided in PHL’s financial statements available at www.promisia.co.nz
PHL and its related companies and their respective directors, employees and representatives make no representation or warranty of any
nature (including as to accuracy or completeness) in respect of this presentation and will have no liability (including for negligence) for any
errors in or omissions from, or for any loss (whether foreseeable or not) arising in connection with the use of or reliance on, information in
this presentation.

---

Promisia Healthcare Limited

Preliminary Unaudited Consolidated Financial
Statements
For the year ended 31 March 2026

2


Promisia Healthcare Limited
Consolidated statement of comprehensive income
For the year ended 31 March 2026


2026
$
'000
2025
$
'000
Revenue

Care and village fees 37,856 29,690
Deferred management fees (DMF) 2,243 1,277
Gain on signing new occupancy right agreements 20 113
Total revenue 40,119 31,080
Other income

Fair value gain on investment property 11,651 173
Bargain purchase on business acquisitions - 6,609
Debt reduction income - 799
Total other income 11,651 7,581
Total revenue and other income 51,770 38,661
Less: expenses

Operating expenses (30,237) (24,777)
Administration expenses (3,472) (3,399)
Depreciation expense (519) (409)
Impairment losses
Finance costs
(37) (491)
- Borrowing costs (2,313) (2,448)
- Vendor loan and convertible note imputed interest expense (1,252) (456)
Total expenses (37,830) (31,980)
Profit before income tax expense 13,940 6,681
Income tax expense (1,017) (107)
Net profit from continuing operations 12,923 6,574
Net profit from discontinued operations - 262
Profit for the year
Other comprehensive income
12,923 6,836
Items that will not be reclassified to profit or loss

Revaluation of property, net of tax
Items that will be reclassified to profit or loss when specific
2,841 1,432
conditions are met

Fair value gain on hedged interest rate swaps 118 -
Total comprehensive income attributable to shareholders of the Company 15,882 8,268

Earnings per share (cents per share)
Basic earnings per share from continuing operations


24.5200


13.4145
Diluted earnings per share from continuing operations 21.4801 11.7235
Basic earnings per share from discontinued operations - 0.5346
Diluted earnings per share from discontinued operations - 0.4672
Basic earnings per share 24.5200 13.9491
Diluted earnings per share

21.4801 12.1908

3
Promisia Healthcare Limited
Consolidated Statement of Financial Position
As at 31 March 2026
2026
$
'000
2025
$
'000
Assets
Cash and cash equivalents 110 132
Receivables 1,504 1,317
Non-current assets held for sale -1,601
Other assets 584 488
Derivative financial instruments 118 -
Right-of-use assets 106 -
Property, plant and equipment 26,964 23,763
Investment properties 170,115 144,785
Total assets 199,501 172,086
Liabilities
Payables 5,044 4,273
Current tax liabilities 1,340 376
Revenue received in advance 5,370 4,056
Convertible notes 2,926 4,465
Occupancy right agreements 88,546 75,058
Borrowings 38,594 42,222
Lease liabilities 110 -
Deferred tax liabilities 2,369 2,364
Total liabilities 144,299 132,814
Net assets 55,202 39,272
Equity
Share capital 82,104 82,056
Reserves 7,457 4,498
Convertible notes reserve 895 1,535
Accumulated losses (35,254) (48,817)
Total equity 55,202 39,272
Net tangible asset per share (dollars) 1.092 0.792

4


Promisia Healthcare Limited
Consolidated statement of changes in equity
For the year ended 31 March 2026



Share capital
$
Accumulated
losses
$
Convertible
notes reserve
$

Reserves
$

Total equity
$
'000 '000 '000 '000 '000
Balance as at 1 April 2024 77,467 (55,653) - 3,066 24,880
Profit for the year - 6,836 - - 6,836
Other comprehensive income - - - 1,432 1,432
Total comprehensive income for
the year
- 6,836 - 1,432 8,268


Transactions with owners in
their capacity as owners:

Contributions
4,589 - - - 4,589
Issue of convertible notes - - 1,535 - 1,535
Total transactions with owners 4,589 - 1,535 - 6,124
in their capacity as owners

Balance as at 31 March 2025 82,056 (48,817) 1,535 4,498 39,272

Balance as at 1 April 2025

82,056

(48,817)

1,535

4,498

39,272
Profit for the year - 12,923 - - 12,923
Other comprehensive income - - - 2,959 2,959
Total comprehensive income - 12,923 - 2,959 15,882
Transactions with owners in
their capacity as owners:

Contributions 48 - - - 48
Convertible notes lapsed - 640 (640) - -
Total transactions with owners 48 640 (640) - 48
in their capacity as owners

Balance as at 31 March 2026 82,104 (35,254) 895 7,457 55,202

5


Promisia Healthcare Limited
Consolidated statement of cash flows
For the year ended 31 March 2026


2026
$
'000
2025
$
'000
Cash flows from operating activities:

Receipts from residents for care fees and services 37,995 32,570
Receipts of residents’ loans from new sales 12,505 8,370
Payments to suppliers and employees (34,015) (30,467)
Repayments of residents’ loans (7,430) (4,414)
Interest paid (2,285) (2,655)
Income tax paid (409) -
Net cash provided by operating activities

Cash flows from investing activities:
6,361 3,404
Payment for property, plant and equipment (534) (285)
Purchase of investment property (923) (2,026)
Payment for business combinations, net of cash acquired - (13,905)
Disposal of discontinued operation, net of cash disposed of - 5,660
Proceeds from disposal of non-current assets held for sale 1,579 -
Net cash provided by / (used in) investing activities

122 (10,556)
Cash flows from financing activities:
Proceeds from share issue, net of transaction costs

-

4,589
Net proceeds from / (repayment of) borrowings (6,462) 2,577
Repayment of lease liabilities (43) -
Net cash (used in) / provided by financing activities (6,505) 7,166

Net (decrease) / increase in cash and cash equivalents (22) 14
Cash and cash equivalents at beginning of year 132 118
Cash and cash equivalents at end of financial year 110 132

---

Results announcement


Results for announcement to the market
Name of issuer Promisia Healthcare Limited
Reporting Period 12 months to 31 March 2026
Previous Reporting Period 12 months to 31 March 2025
Currency NZD
Amount (000s) Percentage change
Revenue from continuing
operations
$40,119 29%
Total Revenue $51,770 34%
Net profit/(loss) from
continuing operations
$12,923 97%
Total net profit/(loss) $12,923 89%
Interim/Final Dividend
Amount per Quoted Equity
Security
It is not proposed to pay a dividend for FY26.
Imputed amount per Quoted
Equity Security
Not applicable
Record Date Not applicable
Dividend Payment Date Not applicable
Current period Prior comparable period
Net tangible assets per
Quoted Equity Security
$1.092 $0.792
A brief explanation of any of
the figures above necessary
to enable the figures to be
understood
A detailed results commentary accompanies this announcement.
Authority for this announcement
Name of person

authorised
to make this announcement
Rhonda Sherriff, Chair
Contact person for this
announcement
Francisco Rodriguez Ferrere, Chief Financial Officer
Contact phone number 021 245 1801
Contact email address Francisco.rf@promisia.co.nz
Date of release through MAP

28 May 2026

Unaudited financial statements accompany this announcement.